XTalks

MARCH 1, 2024

In a pivotal move for the food industry, the US Food and Drug Administration (FDA) has unveiled industry guidance for genome edited foods derived from plants. This landmark guidance aims to demystify the FDA’s risk-based approach towards both genome edited foods and all new plant varieties. What is Genome Editing?

Genome 86

Genome Genomics Production Marketing 86

STAT News

FEBRUARY 7, 2023

Complete Genomics, a U.S. firm affiliated with Chinese sequencing giant BGI, on Tuesday announced plans to launch a new line of sequencers it says can decode DNA in larger amounts — and at lower costs — than any instrument on the market.

Genome 98

Genome Genomics DNA Marketing 98

BioPharma Reporter

FEBRUARY 25, 2021

A program at the University Hospital of TÃbingen is the first in Germany to use whole genome sequencing (WGS) to improve the diagnosis of rare diseases and hereditary cancers.

Genome 98

Genome Genomics Regulation Marketing 98

Bio Pharma Dive

FEBRUARY 5, 2025

and as Illumina faces stiff competition in China’s genome sequencing market. Analysts said the move comes amid rising trade tensions with the U.S.

Genome 152

Genome Genomics Marketing 152

STAT News

APRIL 17, 2023

 Salmon that reach market size in 18 months instead of 30. But with the advent of genetic engineering, genes encoding favorable traits in one species (say, that hornless cow) could be spliced into the genomes of other animals. Pigs that are less likely to induce allergic reactions in humans. Read the rest…

Genome 98

Genome Genomics Genetic Engineering Production 98

pharmaphorum

NOVEMBER 23, 2021

Genomics England, the Department of Health and Social Care’s genome-sequencing hub, has this year announced that support for whole genome sequencing (WGS) has reached a level at which its national rollout on the NHS may someday become a reality. Only when genomic databases are diverse can we ensure that we all benefit equally.

Genome 116

Genome Genomics Genetics Doctors 116

Pharmaceutical Technology

MAY 25, 2023

The Yellow Card biobank will launch as a joint venture with the UK-government funded entity Genomics England on June 1. The pilot phase of the project will focus on the drug allopurinol, which is used to treat gout by lowering uric acid in your blood and is marketed by several companies including Aspen Pharmacare as Zyloric in the UK.

Biobanking 130

Biobanking Genetics Genome Project Genome 130

BioSpace

OCTOBER 7, 2020

10X Genomics just agreed to acquire ReadCoor, Inc., The $350 million deal comes on the heels of 10x Genomics’ August acquisition of CartaNA AB, a Stockholm-based developer of in situ RNA analysis technology. an innovator in the nascent field of in situ technology.

Genome 57

Genome Genomics RNA Marketing 57

BioPharma Reporter

OCTOBER 9, 2023

Congenica, a digital health company providing software and solutions for the analysis and interpretation of genomic data at scale, has announced a two-year extension to its contract for the Hong Kong Genome Project (HKGP), the first large-scale genome sequencing initiative in Hong Kong.

Genome Project 59

Genome Project Genome Genomics Regulation 59

BioPharma Reporter

OCTOBER 4, 2022

Alexion, AstraZeneca Rare Disease will acquire LogicBio Therapeutics, an American genomic medicine company.

Genome 59

Genome Genomics Medicine Regulation 59

Pharmaceutical Technology

FEBRUARY 13, 2023

With the latest advances in whole genome sequencing , it is increasingly clear that rare epilepsies are largely caused by a single genomic mutation, says Ferraro. New developments in the anti-seizure pipeline Genomic screenings can also be used to sharpen the efficacy of already available treatments.

Research 264

Research Gene Gene Therapy Genome 264

Roots Analysis

FEBRUARY 15, 2022

Gene engineering based on recombination was pioneered in the mid-1990s; Currently, development of gene editing technologies has opened up the possibility of modifying genomic sequences in both eukaryotic and prokaryotic organisms. Genome Editing is a way of making changes in the DNA. Type of Genome Editing: Zinc-Finger Nuclease.

Genome 52

Genome Genomics Gene Editing DNA 52

World of DTC Marketing

DECEMBER 29, 2020

Both the Pfizer and Moderna vaccines copied RNA sequence from the virus genome and found a way to manufacture it at scale with high-level processes and quality control. It’s estimated that the COVID 19 vaccine market could be worth almost $100 billion. 1455NO-HEALTH-CORONAVIRUS_VACCINES_PFIZER_O_.

Vaccine 307

Vaccine Vaccination Development Clinical Trials 307

pharmaphorum

AUGUST 4, 2022

Unlocking the secrets of the human genome has long been an ambitious pursuit for researchers around the world. Today, the landscape of genomic testing and research is rapidly progressing, with significant scientific and technological advances driving a paradigm shift in the understanding of oncology at a molecular level.

Genome 52

Genome Genomics Genome Project DNA 52

BioPharma Reporter

MAY 20, 2024

CRISPR licensing company ERS Genomics and drug discovery firm IRBM have entered into a non-exclusive CRISPR/Cas9 license agreement.

Licensing 52

Licensing Licensing Genome Genomics 52

Roots Analysis

AUGUST 28, 2022

The up-and-coming field of spatial genomics in biology promises to bridge the gap between high plex, high throughput, and high resolution. 70+ spatial Genomics solutions are developed by industry and non-industry players. 70+ spatial Genomics solutions are developed by industry and non-industry players. Concluding Remarks.

Genome 52

Genome Genomics RNA Genome Project 52

The Pharma Data

JANUARY 31, 2021

(NASDAQ: ILMN), the global leader in DNA sequencing and array-based technologies, and Sequoia Capital China , a leading investment firm, today announced a collaboration to catalyze the startup ecosystem in China with the launch of the Sequoia Capital China Intelligent Healthcare Genomics Incubator, Powered by Illumina.

Genome 52

Genome Genomics Life Science DNA 52

BioTech 365

OCTOBER 5, 2021

Whole Genome And Exome Sequencing Markets, Q4 2021 Market Report – ResearchAndMarkets.com Whole Genome And Exome Sequencing Markets, Q4 2021 Market Report – ResearchAndMarkets.com DUBLIN–(BUSINESS WIRE)–The “Whole Genome And Exome Sequencing Markets” report has been added to ResearchAndMarkets.com’s offering. (..)

Genome 40

Genome Genomics Marketing 40

The Pharma Data

MARCH 7, 2022

Decision Regarding Slick-Haired Cattle is Agency’s First Enforcement Discretion Decision for an Intentional Genomic Alteration in an Animal for Food Use. IGAs are alterations made using molecular technologies that introduce changes to the genome of an animal. Today, the U.S. Solomon, D.V.M., Related Information.

Genome 52

Genome Genomics Production Marketing 52

BioPharma Reporter

MARCH 3, 2022

Stevenage Bioscience Catalyst (SBC) has launched an accelerator program for biotech start-ups focusing on data-enabled drug discovery, genomics and advanced therapies: aiming to give such companies the skills they need to get potential new drugs and therapies to market more quickly.

Genome 111

Genome Genomics Marketing Drugs 111

BioTech 365

OCTOBER 4, 2021

Global Optical Genome Mapping Market Competition Forecast & Opportunities 2021-2026 – ResearchAndMarkets.com Global Optical Genome Mapping Market Competition Forecast & Opportunities 2021-2026 – ResearchAndMarkets.com DUBLIN–(BUSINESS WIRE)–The “Global Optical Genome Mapping Market By Component (Instruments v/s (..)

Genome 40

Genome Genomics Marketing 40

pharmaphorum

JANUARY 29, 2021

Genome editing is an exciting but still nascent field, and companies in the area face as many obstacles as they do opportunities. ZFPs can be engineered to make zinc finger nucleases, or ZFNs, which are proteins that can be used to edit genomes by knocking select genes in or out to specifically modify DNA sequences.

Gene Editing 145

Gene Editing Gene Gene Therapy In-Vivo 145

BioTech 365

DECEMBER 20, 2021

Genome Editing/Genome Engineering Market Research Report 2021: Technology (CRISPR, TALEN, ZFN, Antisense), Product & Service, Application (Cell Line Engineering, Genetic Engineering, Diagnostics) – ResearchAndMarkets.com Genome Editing/Genome Engineering Market Research Report 2021: Technology (CRISPR, TALEN, ZFN, Antisense), Product & (..)

Genetic Engineering 40

Genetic Engineering Engineer Genome Genomics 40

Outsourcing Pharma

SEPTEMBER 14, 2023

company Rome Therapeutics plans to use the proceeds of its $72 million Series B round to take an experimental autoimmune disease treatment through early clinical testing.

Genome 103

Genome Genomics Regulation Marketing 103

BioPharma Reporter

JUNE 23, 2022

BIO, the worldâs largest trade association for the biotech industry, has responded to the US Food and Drug Administration's draft guidance on developing human gene therapy products that incorporate genome editing (GE) of human somatic cells.

Gene Therapy 59

Gene Therapy Genome Genomics Gene 59

BioTech 365

SEPTEMBER 6, 2021

Global Genome Editing Market Segment Forecasts 2021-2028: Cell Line Engineering Dominates the Market – ResearchAndMarkets.com Global Genome Editing Market Segment Forecasts 2021-2028: Cell Line Engineering Dominates the Market – ResearchAndMarkets.com DUBLIN–(BUSINESS WIRE)–The “Global Genome Editing Market Size, Share (..)

Genome 40

Genome Genomics Engineer Marketing 40

BioPharma Reporter

NOVEMBER 10, 2021

The company recently opened a manufacturing and commercial hub in Singapore, making the facility its first outside of the US.

Genome 92

Genome Genomics Manufacturing Regulation 92

The Pharma Data

NOVEMBER 30, 2020

The license from ERS Genomics now enables Vivlion to offer both R&D reagents and screening services to its customers worldwide. “The The unique 3Cs technology developed by Vivlion significantly expands the use of CRISPR/Cas libraries for target discovery and drug development,” said Eric Rhodes, CEO of ERS Genomics. “It

Genome 52

Genome Genomics Licensing Licensing 52

STAT News

OCTOBER 25, 2022

firm best known for its niche approach to DNA sequencing, on Tuesday announced plans to launch a new product that will put the company in direct competition with genomics juggernaut Illumina. The new DNA sequencer, dubbed Onso, reads the genome in small pieces and uses software to stitch that information together.

DNA 98

DNA Production Genome Genomics 98

BioTech 365

SEPTEMBER 2, 2021

Worldwide Genomics Industry to 2026 – Featuring Agilent Technologies, Bayer Aktiengesellschaft and BGI Genomics Among Others – ResearchAndMarkets.com Worldwide Genomics Industry to 2026 – Featuring Agilent Technologies, Bayer Aktiengesellschaft and BGI Genomics Among Others – ResearchAndMarkets.com DUBLIN–(BUSINESS WIRE)–The (..)

Genome 40

Genome Genomics Marketing 40

BioPharma Reporter

SEPTEMBER 19, 2023

The UK startup Broken String Biosciences has raised a $15 million Series A round to fund the development of a DNA sequencing platform that maps off-target DNA breaks resulting from genome editing technology.

Genome 52

Genome Genomics DNA Development 52

Pharmaceutical Technology

OCTOBER 26, 2022

The biotherapeutics market is rapidly growing, with 2021 seeing the highest-ever cell and gene therapy approval number. New doors were opened in the 2000s with the development of genome editing, such as CRISPR-Cas9, which introduces molecular tools to change existing DNA. The future of cell and gene therapies.

Gene Therapy 130

Gene Therapy Gene Marketing Manufacturing 130

XTalks

MARCH 13, 2025

In 2025, as market pressures intensify and companies refocus on core strategic priorities, medical device and medtech companies have been forced to make tough decisions regarding their workforces. This targeted reorganization is designed to align resources with its core genomics priorities.

Genome 66

Genome Genomics Marketing Manufacturing 66

Outsourcing Pharma

SEPTEMBER 12, 2023

The AstraZeneca-owned company Alexion has teamed up with Verge Genomics to deploy the U.S. startupâs drug discovery platform in the search for novel drug targets for rare neurodegenerative and neuromuscular diseases.

Genome 52

Genome Genomics Drugs Research 52

BioTech 365

NOVEMBER 19, 2021

Global Sequencing Reagents Market (2021 to 2028) – Featuring Agilent Technologies, BGI Genomics and Qiagen Among Others – ResearchAndMarkets.com Global Sequencing Reagents Market (2021 to 2028) – Featuring Agilent Technologies, BGI Genomics and Qiagen Among Others – ResearchAndMarkets.com DUBLIN–(BUSINESS WIRE)–The (..)

Reagent 40

Reagent Genome Genomics Marketing 40

Roots Analysis

FEBRUARY 27, 2024

The global genome editing market is anticipated to grow at a CAGR of 12.6% The global genome editing market is anticipated to grow at a CAGR of 12.6% The immense benefits offered by CRISPR makes it one of the most preferred genome editing approach. during the forecast period 2023-2035.

Genome 40

Genome Genomics Gene In-Vivo 40

Intouch Solutions

NOVEMBER 20, 2023

In the rapidly changing landscape of global markets, staying ahead of the curve is crucial for businesses aiming to expand and thrive. As we step into 2024, the realm of market access undergoes dynamic shifts influenced by technological advancements, policy changes, and evolving consumer behaviors.

Marketing 105

Marketing Manufacturing Genome Genomics 105